Key Takeaways
- RBC Capital Markets increased its 12-month S&P 500 forecast from 7,750 to 7,900
- The revised forecast suggests a potential 7.7% increase from Thursday’s closing level of 7,335.66
- The firm points to a split economic environment where artificial intelligence companies thrive while other sectors struggle
- The healthcare sector received a downgrade to Market Weight amid negative earnings trends and capital flight
- Key concerns include elevated semiconductor sector valuations and ongoing Middle East tensions
RBC Capital Markets has elevated its S&P 500 forecast to 7,900, marking an increase from its previous projection of 7,750. The adjustment was announced Friday by Lori Calvasina, who leads U.S. strategy for the investment bank.
This revised outlook follows the S&P 500’s impressive surge of more than 16% since hitting bottom on March 30. With Thursday’s close at 7,335.66, the updated target represents approximately 7.7% potential gains from current levels.
The bank’s revised projection stems from its valuation and earnings-per-share framework, chosen over averaging its five different forecasting approaches. According to RBC’s strategists, this particular methodology better captures the dynamics of what they describe as a bifurcated economic environment.
This characterization highlights a clear divide across market segments. Companies tied to artificial intelligence continue delivering robust profit growth, while other index components contend with challenges stemming from the Middle East crisis.
RBC applied a 5% discount to consensus bottom-up earnings projections for Q1 2027, arriving at approximately $329 per share. While AI sector estimates remained aligned with consensus expectations, forecasts for the broader index were reduced by 7.5%.
Economic Framework Supporting the Forecast
The firm’s projection incorporates several macroeconomic variables. RBC anticipates inflation will reach 3.3%, exceeding consensus predictions. Additionally, the analysis assumes the Federal Reserve maintains current interest rates while 10-year Treasury yields stabilize around 4.5%.
These parameters generate a trailing price-to-earnings ratio of approximately 24 times earnings.
RBC acknowledged that combining all five forecasting models would yield an even more aggressive target of 8,100. However, the firm selected 7,900 as its official position, believing it appropriately balances potential opportunities against existing vulnerabilities.
This announcement aligns with similar bullish revisions from J.P. Morgan and Barclays during the previous month. Both institutions pointed to diminishing geopolitical concerns and strengthening corporate earnings as justification for their upgraded outlooks.
RBC maintained its strategic preference for growth-oriented investments over value plays within large-cap stocks. The firm also continues favoring domestic equities relative to international markets while adopting a measured optimistic stance toward small-cap opportunities.
Healthcare Sector Receives Downgrade
Accompanying the target increase, RBC implemented one notable sector adjustment. The firm lowered its assessment of U.S. healthcare equities to Market Weight from its previous Overweight recommendation.
This downgrade reflects worsening earnings estimate revisions, substantial investor capital withdrawals, and disappointing findings from RBC’s latest analyst survey.
RBC identified multiple factors that could challenge its forecast. These include possible additional reductions to 2027 earnings expectations and excessive valuations within the semiconductor industry.
The firm identified the Middle East situation as the most significant downside risk that could potentially trigger a U.S. economic contraction. Nevertheless, RBC noted that most publicly traded corporations have indicated they possess adequate tools to navigate current disruptions.
Last month, the S&P 500 recorded its largest monthly percentage advance since November 2020.
